Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Enriching the French health care database with external data greatly improved its usefulness.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

More hair-loss studies are needed with standardized outcomes and diverse participants.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

High doses of some contraceptive steroids cause health issues in dogs, but their relevance to humans is unclear.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Finasteride safety data in trials may be underreported or misrepresented.

Finasteride toxicity information is limited, poor quality, and biased.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The commentary stresses the importance of using historical control data and proper interpretation in evaluating developmental toxicity.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

All HPV vaccine studies should be registered and published to reduce reporting bias.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.